Mesenchymal stem cells from healthy volunteers (N‐ADSC) and those from patients with type II diabetes (T2DM‐ADSC) have been verified to be positive for the following stem cell markers: CD13, CD29, CD44, CD73, CD90, CD105, and CD166. This evidence concerns the gene THY1 and type 2 diabetes mellitus.